86 related articles for article (PubMed ID: 16269401)
1. Postoperative treatment with low molecular weight heparin after right heart assist for coronary artery bypass grafting.
Hughes P; Hasenkam JM; Severinsen IK; Steinbrüchel DA
Scand Cardiovasc J; 2005 Oct; 39(5):306-12. PubMed ID: 16269401
[TBL] [Abstract][Full Text] [Related]
2. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
3. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
Sandner SE; Zimpfer D; Zrunek P; Steinlechner B; Rajek A; Schima H; Wolner E; Wieselthaler GM
Artif Organs; 2008 Oct; 32(10):819-22. PubMed ID: 18959671
[TBL] [Abstract][Full Text] [Related]
6. Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG).
Lisowski P; Małyszko J; Hirnle T; Lisowska A; Jackowski R; Małyszko JS; Buzun L; Myśliwiec M
Rocz Akad Med Bialymst; 2005; 50():166-72. PubMed ID: 16358959
[TBL] [Abstract][Full Text] [Related]
7. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J
Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
9. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.
Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256
[TBL] [Abstract][Full Text] [Related]
10. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
Marmur JD; Lakhani M; El Rouby S; Cavusoglu E
J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
[TBL] [Abstract][Full Text] [Related]
11. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery.
Raivio P; Fernández JA; Kuitunen A; Griffin JH; Lassila R; Petäjä J
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):44-51. PubMed ID: 17198779
[TBL] [Abstract][Full Text] [Related]
12. Pericardial fluid and serum VEGF in response to different types of heparin treatment.
Gerrah R; Tshori S; Gilon D
Int J Cardiol; 2004 Apr; 94(2-3):193-6. PubMed ID: 15093980
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
PRIME CARE Study Investigators Group
Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
16. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
17. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
Gulbins H; Malkoc A; Ennker IC; Ennker J
Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
[TBL] [Abstract][Full Text] [Related]
18. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.
Meuris B; Arnout J; Vlasselaers D; Schetz M; Meyns B
Artif Organs; 2007 May; 31(5):402-5. PubMed ID: 17470211
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
[TBL] [Abstract][Full Text] [Related]
20. Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study.
Jochberger S; Mayr V; Luckner G; Fries DR; Mayr AJ; Friesenecker BE; Lorenz I; Hasibeder WR; Ulmer H; Schobersberger W; Dünser MW
Crit Care; 2005 Oct; 9(5):R541-8. PubMed ID: 16277716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
